Quarterly Focus Issue: Prevention/OutcomeClinical Research: Chronic Coronary Artery DiseaseIntensive Multifactorial Intervention for Stable Coronary Artery Disease: Optimal Medical Therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
Clinical Research: Chronic Coronary Artery Disease
Under an Elsevier user license
open archive
Key Words
coronary disease
medical therapy
risk factors
secondary prevention
Abbreviations and Acronyms
ACC
American College of Cardiology
AHA
American Heart Association
CAD
coronary artery disease
HbA1c
hemoglobin A1c
LDL
low-density lipoprotein
MI
myocardial infarction
OMT
optimal medical therapy
PCI
percutaneous coronary intervention
Cited by (0)
This work was supported by the Cooperative Studies Program of the U.S. Department of Veterans Affairs Office of Research and Development, in collaboration with the Canadian Institutes of Health Research; and by unrestricted research grants from Merck, Pfizer, Bristol- Myers Squibb, Fujisawa, Kos Pharmaceuticals, Datascope, AstraZeneca, Key Pharmaceutical, Sanofi-Aventis, First Horizon, and GE Healthcare, including in-kind support with Food and Drug Administration-approved drugs used by study participants. All industrial funding in support of the trial was directed through the U.S. Department of Veterans Affairs. For full author disclosures please see the end of this paper.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.